Distribution and activity of transglutaminase in rat brain carcinogenesis and in gliomas

Cancer Letters

Volumn 140, Issue 1-2, 1999, Pages 47-51

  Tunici, Patrizia ^a   Sessa, Angela ^b   Rabellotti, Elisa ^a   Calloni, Annika ^a   Perin, Antonio ^a,b  

^a Ctro Interdipartimentale Per R   (Italy)

^b CNR   (Italy)

Author keywords

Brain carcinogenesis; Gliomas; N ethyl N nitrosourea; Tissue transglutaminase

Indexed keywords

ETHYLNITROSOUREA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CANCER; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GLIOMA; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; RAT;

ANIMALS; ANIMALS, NEWBORN; BRAIN; BRAIN NEOPLASMS; CARCINOGENICITY TESTS; CARCINOGENS; CYTOSOL; ETHYLNITROSOUREA; FEMALE; GLIOMA; MALE; MATERNAL-FETAL EXCHANGE; PREGNANCY; RATS; SUBCELLULAR FRACTIONS; TIME FACTORS; TRANSGLUTAMINASES;

EID: 0032972409     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00049-X     Document Type: Article

References (35)

1. Greenberg C.S., Birckbichler P.J., Rice R.H. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J. 5:1991;3071-3077.
2. Byrd J.C., Lichti U. Two types of transglutaminase in the PC12 pheochromocytoma cell line. Stimulation by sodium butyrate. J. Biol. Chem. 262:1987;11699-11705.
3. Nara K., Nakanishi K., Hagiwara H., Wakita K., Kojima S., Hirose S. Retinol-induced morphological changes of cultured bovine endothelial cells are accompanied by a marked increase in transglutaminase. J. Biol. Chem. 264:1989;8-19312.
4. Gentile V., Thomazy V., Piacentini M., Fesus L., Davies P.J.A. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: effects on cellular morphology and adhesion. J. Cell Biol. 119:1992;463-474.
5. 2-macroglobulin and polypeptide hormones. Nature. 283:1980;162-167.
6. Cai D., Ben T., De Luca L.M. Retinoids induce tissue transglutaminase in NIH-3T3 cells. Biochem. Biophys. Res. Commun. 175:1991;1119-1124.
7. Slife C.W., Dorsett M.D., Tillotson M.L. Subcellular location and identification of a large molecular weight substrate for the liver plasma membrane transglutaminase. J. Biol. Chem. 261:1986;3451-3456.
8. Martinez J., Chalupowicz D.G., Roush R.K., Sheth A., Barsigian C. Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry. 33:1994;2538-2545.
9. Kleman J.-Ph., Aeschlimann D., Paulsson M., van der Rest M. Transglutaminase-catalyzed cross-linking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry. 34:1995;13768-13775.
10. Hettasch J.M., Bandarenko N., Burchette J.L., Lai T.S., Marks J.R., Haroon Z.A., Peters K., Dewhirst M.W., Iglehart J.D., Greenberg C.S. Tissue transglutaminase expression in human breast cancer. Lab. Invest. 75:1996;637-645.
11. Barsigian C., Stern A.M., Martinez J. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio]imidazolium derivatives as cellular transglutaminase inactivators. J. Biol. Chem. 266:1991;22501-22509.
12. Raghunath M., Höpfner B., Aeschlimann D., Lüthi U., Meuli M., Altermatt S., Gobet R., Bruckner-Tuderman L., Steinmann B. Cross-linking of the dermo-epidermal junctions of skin regenerating from keratinocyte autografts. Anchoring fibrils are a target for tissue transglutaminase. J. Clin. Invest. 98:1996;1174-1184.
13. Fésüs L., Thomazy V., Falus A. Induction and activation of tissue transglutaminase during programmed cell death. FEBS Lett. 224:1987;104-108.
14. Fukuda K., Kojiro M., Chiu J.F. Induction of apoptosis by transforming growth factor-β1 in the rat hepatoma cell line McA-RH7777: a possible association with tissue transglutaminase expression. Hepatology. 18:1993;945-953.
15. Griffin M., Knight R.C., Rees R.C., Elliott B.M. Transglutaminase activity, tumor growth and metastasis. Biochem. Soc. Trans. 17:1989;714-715.
16. Beninati S., Abbruzzese A., Cardinali M. Differences in the post-translational modification of proteins by polyamines between weakly and higly metastatic B16 melanoma cells. Int. J. Cancer. 53:1993;792-797.
17. Knight C.R.L., Rees R.C., Elliott B.M., Griffin M. The existence of an inactive form of transglutaminase within metastasising tumours. Biochim. Biophys. Acta. 1053:1990;13-20.
18. Ohashi H., Itoh Y., Birckbichler P.J., Takeuchi Y. Purification and characterization of rat brain transglutaminase. J. Biochem. 118:1995;1271-1278.
19. Hand D., Perry M.J.M., Haynes L.W. Cellular transglutaminases in neural development. Int. J. Dev. Neurosci. 11:1993;709-720.
20. Lorand L. Neurodegenerative diseases and transglutaminase. Proc. Natl. Acad. Sci. USA. 93:1996;14310-14313.
21. Iwaki T., Miyazono M., Hitotsumatsu T., Tateishi J. An immunohistochemical study of tissue transglutaminase in gliomas with reference to their cell dying processes. Am. J. Pathol. 145:1994;776-781.
22. Rohn G., Ernestus R.I., Schroder R., Hossmann K.A., Klug N., Paschen W. Transglutaminase activity in human brain tumors. Acta Histochem. 42:1992;155-158.
23. Kleihues P., Lantos P.L., Magee P.N. Chemical carcinogenesis in the nervous system. Richter G.W., Epstein M.A. International Review of Experimental Pathology. 15:1976;153 Academic Press, New York.
24. Folk J.E., Cole P.W. Transglutaminase: mechanistic features of the active site as determined by kinetic and inhibitor studies. Biochim. Biophys. Acta. 122:1966;244-264.
25. Piacentini M., Sartori C., Beninati S., Barqaqli A.M., Cerù-Argento M.P. Ornithine decaboxylase, transglutaminase, diamine oxidase and total diamines and polyamines in maternal liver and kidney throughout rat pregnancy. Biochem. J. 234:1986;435-440.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
27. Koestner A., Swenberg J.A., Wechsler W. Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague-Dawley rats. Am. J. Pathol. 63:1971;37-56.
28. Folkman J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82:1990;4-6.
29. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. New Engl. J. Med. 324:1991;1-8.
30. Delcros J.G., Bard S., Roch A.M., Quash G., Poupon M.F., Korach S. Transglutaminase activity and putrescine-binding capacity in cloned cell lines with different metastatic potential. FEBS Lett. 196:1986;325-330.
31. Hand D., Elliott B.M., Griffin M. Characterization of the cellular substrates for transglutaminase in normal liver and hepatocellular carcinoma. Biochim. Biophys. Acta. 1033:1990;57-64.
32. Schuber F. Influence of polyamines on membrane functions. Biochem. J. 260:1989;1-10.
33. 8 position in rat brain and in N-ethyl-N-nitrosourea-induced gliomas. Cancer Lett. 76:1994;121-125.
34. Birckbichler P.J., Orr G.R., Patterson M.K. Jr. Differential transglutaminase distribution in normal rat liver and rat hepatoma. Cancer Res. 36:1976;2911-2914.
35. Barnes R.N., Bungay P.J., Elliott B.M., Walton P.L., Griffin M. Alterations in the distribution and activity of transglutaminase during tumor growth and metastasis. Carcinogenesis. 6:1985;459-463.